Your browser doesn't support javascript.
loading
Surgical treatment in clinical stage iv gastric cancer: a comparison of different procedures and survival outcomes / Tratamento cirúrgico no câncer gástrico estágio clínico iv: uma comparação de diferentes procedimentos e resultados de sobrevida
RAMOS, Marcus Fernando Kodama Pertille; PEREIRA, Marina Alessandra; DIAS, André Roncon; CASTRIA, Tiago Biachi de; SAKAMOTO, Erica; RIBEIRO-JR, Ulysses; ZILBERSTEIN, Bruno; NAHAS, Sérgio Carlos.
  • RAMOS, Marcus Fernando Kodama Pertille; University of Sao Paulo. Faculty of Medicine. Gastroenterology Department. Sao Paulo. BR
  • PEREIRA, Marina Alessandra; University of Sao Paulo. Faculty of Medicine. Gastroenterology Department. Sao Paulo. BR
  • DIAS, André Roncon; University of Sao Paulo. Faculty of Medicine. Gastroenterology Department. Sao Paulo. BR
  • CASTRIA, Tiago Biachi de; University of Sao Paulo. Faculty of Medicine. Gastroenterology Department. Sao Paulo. BR
  • SAKAMOTO, Erica; University of Sao Paulo. Faculty of Medicine. Gastroenterology Department. Sao Paulo. BR
  • RIBEIRO-JR, Ulysses; University of Sao Paulo. Faculty of Medicine. Gastroenterology Department. Sao Paulo. BR
  • ZILBERSTEIN, Bruno; University of Sao Paulo. Faculty of Medicine. Gastroenterology Department. Sao Paulo. BR
  • NAHAS, Sérgio Carlos; University of Sao Paulo. Faculty of Medicine. Gastroenterology Department. Sao Paulo. BR
ABCD (São Paulo, Online) ; 35: e1648, 2022. tab, graf
Article in English | LILACS-Express | LILACS | ID: biblio-1383205
ABSTRACT
ABSTRACT -

BACKGROUND:

Even in clinical stage IV gastric cancer (GC), surgical procedures may be required to palliate symptoms or in an attempt to improve survival. However, the limited survival of these patients raises doubts about who really had benefits from it.

AIM:

This study aimed to analyze the surgical outcomes in stage IV GC treated with surgical procedures without curative intent.

METHODS:

Retrospective analyses of patients with stage IV GC submitted to surgical procedures including tumor resection, bypass, jejunostomy, and diagnostic laparoscopy were performed. Patients with GC undergoing curative gastrectomy served as the comparison group.

RESULTS:

Surgical procedures in clinical stage IV were performed in 363 patients. Compared to curative surgery (680 patients), stage IV patients had a higher rate of comorbidities and ASA III/IV classification. The surgical procedures that were performed included 107 (29.4%) bypass procedures (partitioning/gastrojejunal anastomosis), 85 (23.4%) jejunostomies, 76 (20.9%) resections, and 76 (20.9%) diagnostic laparoscopies. Regarding patients' characteristics, resected patients had more distant metastasis (p=0.011), bypass patients were associated with disease in more than one site (p<0.001), and laparoscopy patients had more peritoneal metastasis (p<0.001). According to the type of surgery, the median overall survival was as follows resection (13.6 months), bypass (7.8 months), jejunostomy (2.7 months), and diagnostic (7.8 months, p<0.001). On multivariate analysis, low albumin levels, in case of more than one site of disease, jejunostomy, and laparoscopy, were associated with worse survival.

CONCLUSION:

Stage IV resected cases have better survival, while patients submitted to jejunostomy and diagnostic laparoscopy had the worst results. The proper identification of patients who would benefit from surgical resection may improve survival and avoid futile procedures.
RESUMO
RESUMO - RACIONAL Mesmo no câncer gástrico (CG) em estágio clínico IV (ECIV), procedimentos cirúrgicos podem ser necessários para aliviar sintomas ou na tentativa de melhorar a sobrevida. No entanto, a sobrevida limitada desses pacientes levanta dúvidas sobre quem realmente se beneficiaria.

OBJETIVO:

Analisar os resultados cirúrgicos do CG ECIV tratado com procedimentos cirúrgicos sem intenção curativa.

MÉTODOS:

Análise retrospectiva dos pacientes com CG ECIV submetido a procedimentos cirúrgicos, incluindo ressecção tumoral, bypass, jejunostomia e laparoscopia diagnóstica. Pacientes submetidos à gastrectomia curativa serviram como grupo de comparação.

RESULTADOS:

Os procedimentos cirúrgicos em ECIV foram realizados em 363 pacientes. Comparado à cirurgia curativa (680 pacientes), os pacientes em ECIV apresentaram maior taxa de comorbidades e classificação ASA III/IV. Os procedimentos cirúrgicos realizados foram 107 (29,4%) bypass (partição/anastomose gastrojejunal), 85 (23,4%) jejunostomias, 76 (20,9%) ressecções e 76 (20,9%) laparoscopias diagnósticas. Em relação às características dos pacientes, os ressecados apresentaram predomínio de metástases distantes (p=0,011); os de bypass associaram-se a doença em mais de um sítio (p<0,001); e os laparoscópicos, metástases peritoneais (p<0,001). A sobrevida global mediana de acordo com o tipo de cirurgia foi ressecção (13,6 meses), bypass (7,8 meses), jejunostomia (2,7 meses) e diagnóstica (7,8 meses) (p<0,001). Na análise multivariada, níveis baixos de albumina, mais de um sítio de doença, jejunostomia e laparoscopia associaram-se a pior sobrevida.

CONCLUSÃO:

Pacientes em ECIV ressecados apresentam melhor sobrevida, enquanto aqueles submetidos à jejunostomia e laparoscopia diagnóstica tiveram piores resultados. A identificação adequada dos pacientes que se beneficiariam com a ressecção cirúrgica pode melhorar a sobrevida e evitar procedimentos pouco eficazes.


Full text: Available Index: LILACS (Americas) Type of study: Prognostic study Language: English Journal: ABCD (São Paulo, Online) Year: 2022 Type: Article Affiliation country: Brazil Institution/Affiliation country: University of Sao Paulo/BR

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Index: LILACS (Americas) Type of study: Prognostic study Language: English Journal: ABCD (São Paulo, Online) Year: 2022 Type: Article Affiliation country: Brazil Institution/Affiliation country: University of Sao Paulo/BR